Polatuzumab vedotin plus bendamustine and rituximab increased complete response rates to 40% among patients with diffuse large B-cell lymphoma.
Top news of the week from Specialty Pharmacy Times.
A look at the most read drug approval articles of 2017 covered by Specialty Pharmacy Times.
Cigarette smoking played a role in 19% of cancers and 29% of cancer-related deaths in 2014.
A look back at the debate around direct and indirect remuneration fees in 2017.
Enzymes that protect the immune system may malfunction and provoke cancer-related mutations.
A review of the most popular video interviews on Specialty Pharmacy Times.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.